National Bank of Canada’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $90.1K | Sell |
4,153
-51
| -1% | -$1.11K | ﹤0.01% | 1491 |
|
|
2025
Q1 | $102K | Buy |
4,204
+2
| +0% | +$48 | ﹤0.01% | 1404 |
|
|
2024
Q4 | $87.7K | Sell |
4,202
-1,026
| -20% | -$21.4K | ﹤0.01% | 1442 |
|
|
2024
Q3 | $104K | Sell |
5,228
-272
| -5% | -$5.41K | ﹤0.01% | 1352 |
|
|
2024
Q2 | $86.5K | Hold |
5,500
| – | – | ﹤0.01% | 1384 |
|
|
2024
Q1 | $87.6K | Buy |
+5,500
| New | +$87.6K | ﹤0.01% | 1406 |
|
|
2023
Q4 | – | Sell |
-200
| Closed | -$2.35K | – | 2548 |
|
|
2023
Q3 | $2.35K | Hold |
200
| – | – | ﹤0.01% | 2264 |
|
|
2023
Q2 | $2.69K | Hold |
200
| – | – | ﹤0.01% | 2264 |
|
|
2023
Q1 | $3.32K | Buy |
200
+34
| +20% | +$564 | ﹤0.01% | 2218 |
|
|
2022
Q4 | $3.09K | Buy |
+166
| New | +$3.09K | ﹤0.01% | 2249 |
|